Patent details

EP2201943 Title: Novel use of a peptide class of compounds for treating diabetic neuropathic pain

Basic Information

Publication number:
EP2201943
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP101575959
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Novel use of a peptide class of compounds for treating diabetic neuropathic pain
French Title of Invention:
Nouvelle utilisation d'une classe peptidique de composés pour traiter la douleur neuropathique diabétique
German Title of Invention:
Neue Verwendung einer Peptidklasse von Verbindungen zur Behandlung von diabetischem neuropathischem Schmerz
SPC Number:

Dates

Filing date:
19/03/2002
Grant date:
03/08/2011
EP Publication Date:
03/08/2011
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/06/2010
EP B1 Publication Date:
03/08/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/03/2012
Expiration date:
19/03/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/03/2002
 
 

Name:
UCB Pharma GmbH
Address:
Alfred-Nobel-Strasse 10, 40789 Monheim, Germany (DE)

Inventor

Name:
Selve Norma
Address:
Germany (DE)

Priority

Priority Number:
01107026
Priority Date:
21/03/2001
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 31/165;
Filing date Document type Number of pages